Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002

Gabrielle Meyers*, Mehdi Hamadani, Michael Martens, Haris Ali, Patrice Chevallier, Hannah Choe, Andrew C. Harris, Ernst Holler, Eric van Hooren, Willem Klaassen, Eric Leifer, Ypke van Oosterhout, Lia Perez, Iskra Pusic, Matthias Stelljes, Walter van der Velden, Emanuele Ammatuna, David Beauvais, Jérôme Cornillon, Richard T. MaziarzJohannes Schetelig, Jennifer Romeril, Margaret L. MacMillan, John E. Levine, Gérard Socié

*Corresponding author for this work

    Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

    2 Citations (Scopus)
    67 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)1416–1418
    Number of pages3
    JournalBone marrow transplantation
    Volume58
    Early online date25-Sept-2023
    DOIs
    Publication statusPublished - Dec-2023

    Cite this